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The identification of somatic mosaicism in the brain
lends a new perspective to our understanding of
the role of gene and environment interactions in
psychiatric disease risk. Somatic mutations, such as
retrotransposon insertions, that are precipitated by
modern environmental factors may alter neuronal
function and neurological traits, increasing the societal
prevalence of mental disorders.or enhancers, or generating novel fusion proteins, as in
the case of long interspersed nuclear element (L1, alsoGenomic diversity in human somatic neural cells
The presence of somatic cells that harbor distinct muta-
tions within one individual is referred to as somatic mo-
saicism, and growing evidence suggests that this is both
a feature of normal brains and, when unchecked, a hall-
mark of disease. Recent advances in single-cell sequen-
cing technology have raised new opportunities to
understand heterogeneity in the brain. New evidence
challenges the basic assumption that neuronal genomes
are static and identical among the cells of an individual.
Instead, extensive genomic diversity has been identified
among the neurons of individuals. A variety of mutations
contribute to somatic mosaicism, including indels, copy
number variants (CNVs), aneuploidy, retrotransposition,
and single nucleotide polymorphisms (SNPs). Single-cell
analyses recently revealed that a third of neural progeni-
tors demonstrate aneuploidy, up to 40 % of neurons
contain megabase-scale CNVs, and neurons contain de
novo retrotransposon insertions. Although the exact rate
of retrotransposition is unclear, estimates from single-
cell analyses predict rates as low as <0.6 insertions per
neuron and as high as 13 insertions per neuron, depend-
ing on the brain region and method of detection [1].
In contrast to germline mutations, which are inherited,
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mutation arises. A somatic mutation that occurs in an
early progenitor during embryogenesis could be passed
on to most cells of the brain and body. Alternatively, a
somatic mutation that occurs in one neural progenitor
in a neurogenic niche of the adult brain may only be
transmitted to a small handful of cells. Depending on its
genomic location, a mutation could have a range of
effects on cellular function by altering gene expression
or transcript splicing, affecting epigenetic modifications
called LINE-1) retrotransposons [1, 2]. Considering the
highly networked state of the brain, a small number of
somatic mutations that affect cellular function could
have far-reaching effects on neuronal circuitry.
Accumulating evidence suggests that environmental
factors drive some types of somatic mutations, particu-
larly retrotransposition and retrotransposon-associated
events [1]. For example, environmental factors that in-
crease L1 expression or impair DNA-damage responses
may increase the rate of retrotransposition (Fig. 1a). L1
is the most abundant class of retrotransposon, compris-
ing about 17 % of mammalian genomes. L1 generates
new insertions by undergoing reverse transcription and
inserting a copy of its own mRNA into the genome dur-
ing cellular division, when the nuclear membrane breaks
down to allow import of the L1 ribonucleoprotein com-
plex. Most retrotransposon copies are truncated or
otherwise mutated such that their mobilization is no
longer possible, but 80–100 copies remain active in the
common reference human genome. Although many cell
types express retrotransposons, dividing cells such as
neural progenitor cells may support increased levels of
retrotransposition [1].
Somatic mosaicism resulting from retrotransposition
or other types of mutations may represent a bridge be-
tween environmental and genetic factors that predispose
individuals to brain disorders. A long-standing question
has been how environmental experiences permanentlyicle is distributed under the terms of the Creative Commons Attribution 4.0
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Fig. 1 Environmental influence on retrotransposition and disease risk. a Environmental factors can increase the rate of retrotransposition by
affecting cellular and molecular processes that act at different levels of the insertion cycle (thunderbolts represent environmental effects).
(1) In the nucleus (dotted line represents the nuclear envelope), full-length long interspersed nuclear element (L1) retrotransposon
elements are transcribed from an internal Pol II promoter. Environmental effects on transcription factor expression or binding, on DNA methylation
of L1 elements, or on heterochromatin structure could increase the transcription of L1, introducing more substrate for potential retrotransposition.
(2) L1 mRNA encodes two proteins: an RNA-binding protein (ORF1p) and a protein with endonuclease and reverse transcriptase domains (ORF2p).
These proteins form a ribonucleoprotein (RNP) complex with L1 mRNA in cis-preference (that is, mRNA from the same L1 element), and this complex
can be imported into the nucleus or sequestered into stress granules and degraded. Environmental factors may influence cellular defenses involved in
the sequestration and degradation of L1 proteins, which could affect the amount of stable L1 RNP complexes available for import into the nucleus.
(3) L1 RNP complexes are imported into the nucleus during cell division when the nuclear envelope is disrupted, or through an unknown import
mechanism. Environmental effects on nuclear permeability or on the rate of cell division could increase the number of L1 RNP complexes imported
into the nucleus, thus increasing availability of the machinery needed for retrotransposition. (4) Once inside the nucleus, L1 endonuclease
nicks the genomic DNA at a TTAAA sequence and the L1 mRNA is inserted via target-primed reverse transcription (pink circle represents
ORF2p reverse transcribing L1 mRNA). Environmental effects on DNA damage, DNA repair processes, or chromatin structure could affect
the accessibility of the genomic DNA and its vulnerability to acquiring a new insertion. b Many neurological phenotypes, for example
stress activity, are normally distributed, with extreme traits at the outer tails of the distribution predicting disease (top graph). The effect
of high levels of somatic mutation on disease risk might be explained by models of additive or neutral risk. An extreme model would
suggest that all somatic variation is associated with additive risk. In this case, the net result would be a shift in the mean of the respective phenotype
(middle graph). Conversely, a more conservative model would posit that somatic events, much like germline mutations, have a largely neutral effect
on the phenotype, with rare events having an equal chance of increasing or decreasing risk. In this case, an accumulation of normally
distributed interacting effects would expand the variance of a distribution while keeping the mean constant (bottom graph). Environmental factors that
accelerate the somatic mutation rate could ultimately expand the phenotypic diversity in an affected population beyond its natural state, potentially
increasing disease risk in the population. If the phenotypic distribution were expanded or shifted, more individuals would exhibit extreme neurological
traits at the outer tails of the distribution
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Here, we explore the implications of somatic mosaicism
in the brain generated in response to the environment
and their consequences for mental health.
Effects of genomic diversity and environmental
factors on disease risk
The total disease risk for a given individual and disorder
is an accumulation of risk from both inherited and non-inherited factors, particularly for certain mental disor-
ders where environmental experience contributes to
disease onset. A large proportion of total psychiatric dis-
ease risk is attributed to germline mutations, with herit-
ability estimates ranging from 30 to 80 % [3]. Despite
the strong inherited component, discordance between
monozygotic twins demonstrates that a portion of
psychiatric and other brain disease etiology is driven by
non-inherited factors, such as environmental perturbations
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such as urban living and early life trauma, confers non-
inherited risk for some psychiatric disorders, such as
schizophrenia [4]; but the mechanistic link between early
environmental events and disease progression is still largely
unknown. The delay between exposure and onset of
disease suggests that the environment induces stable
changes, such as somatic mutations, that have the potential
to manifest later in life.
Traditionally, environmental effects have been ex-
amined in interaction with germline variants. Many of
these inherited alleles are common in the general
population, indicating that no genome is completely
devoid of risk [5]. Instead, there is a landscape of
polygenic risk, where each variant is associated with a
small increase in the odds of developing a particular
disorder. When accumulated, the set of variants, as a
whole, can generate a disease-associated phenotype.
Somatic mutations that are driven by environmental
factors are layered onto this landscape of inherited
risk and may contribute to psychiatric disease by
causing ‘multiple hits’ in an individual who has an
inherited genetic predisposition.
Although somatic retrotransposition occurs at low
rates in the mammalian brain [1], we do not know the
extent to which these variants affect disease risk. One
possibility is that a disease state is associated with an
increased load of new insertions that can drive transcrip-
tional and functional diversity. Both cell lines from Rett
syndrome patients and prefrontal cortex from schizo-
phrenia patients exhibit an increased load of L1 inser-
tions [1]. As mentioned earlier, depending on the stage
of development in which these variants arise, the fre-
quencies of cells that harbor the somatic allele can range
from one single cell per individual to every cell in the
body. Since somatic retrotransposition would affect only
a portion of all of the neurons in an adult, it is possible
that the functional consequences are present at the som-
atic level but that the phenotype is modulated at the
level of the organism.
The true range of effects of somatic variants on neuro-
psychiatric phenotypes should become elucidated with
additional research. Nevertheless, models of neutral risk
or additive risk can be envisaged (Fig. 1b). The latter
could result in an increase in phenotypic variance at the
cellular level, which would be defined in the brain by the
generation of a highly diverse set of neurons. Such diver-
sity is indeed prevalent in the brain and is thought to be
vital for complex information processing [1].
Environmental effects on somatic diversity risk
Much of the evidence gathered to date for environmental
effects on somatic diversity focuses on L1 retrotransposi-
tion. Environmental events drive somatic mosaicism byinstigating molecular or hormonal events that create a
permissive state in which genomic changes can occur. For
example, exposing adult mice to voluntary exercise in-
creases hippocampal neurogenesis, thus increasing the
number of dividing and differentiating cells that are per-
missive to retrotransposition [6]. Similarly, steroid hor-
mones activate L1 elements by binding an androgen
response element in their promoter and increasing their
expression [7]. Given the importance of diversification for
adaptation, it seems reasonable that natural environmental
factors drive genomic diversity to some extent as a form
of plasticity.
Environmental factors that expand this diversity beyond
natural variation may, however, cause genomic instability
and increase disease risk. In modern societies, humans are
exposed to an increasing array of pollutants and toxins,
some of which are man-made and never before encoun-
tered in the environment. Synthetic hormones and orga-
nochloride pesticides increase the transcription of human
L1 retrotransposons [7]. Exposure to heavy metals in-
creases L1 retrotransposition rate three-fold, putatively by
reducing DNA-repair processes that defend against inser-
tions [8]. Benzo-a-pyrene, a pollutant resulting from resi-
dential wood burning, automobile exhausts, and cigarette
smoke, both upregulates L1 expression and increases
retrotransposition [9]. Even exposure to artificial light at
night, which dysregulates circadian rhythms, increases ret-
rotransposition through a mechanism related to depleted
melatonin [10].
The incidence of mental disorders is said to have
increased in recent decades, particularly in modernized
societies, even accounting for improved detection and
diagnoses. The trend may be related, in part, to high
rates of somatic mutation driven by environmental fac-
tors. For example, prenatal immune activation in mice is
associated with both increased rates of retrotransposi-
tion and behavioral deficits reminiscent of schizophrenia;
in humans, a similar correlation exists between prenatal
viral infection, schizophrenia, and L1 copy number [1].
An expanding list of brain disorders, including autism,
Rett syndrome, Alzheimer’s disease, and drug addiction,
is associated with increased somatic mutation rate. Inter-
actions between the environment and somatic mutations
in the brain may contribute to some of these neural
disorders.
In summary, we suggest that somatic mutations may
contribute to the onset of psychiatric or other brain dis-
orders by interacting with inherited genetic variants and
introducing permanent changes to neuronal function.
Somatic mosaicism induced by differences in environ-
mental experience may explain disease discordancy
between monozygotic twins or behavioral variability
among genetically homogeneous laboratory mice. Future
studies should aim to elucidate a causal role of the
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clearly define its relationship with behavioral and neur-
onal phenotypes. With a deeper understanding of how
environmental factors interact with somatic mutations
in the human brain, it may become possible to better
predict and prevent mental disorders in susceptible
individuals.
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